Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOLINE-2: Donepezil added to non-drug care pathway in Alzheimer's disease
2021-001788-26Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of donepezil in Alzheimer's disease (AD) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Change in MMSE score at 6 months. Started May 2021; status: active.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2021-001788-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001788-26.